Sign inJoin waitlistJoin the waitlist

GI

Gopa Iyer

Deputy Program Director · New York Presbyterian Hospital

Credentials: · · · ·

History

New York Presbyterian Hospital
Present
Bladder Cancer Section · New York Presbyterian Hospital
Present

Memorial Sloan Kettering Cancer Center
2006–2008
Internal Medicine
University of Michigan
2003–2006
Vanderbilt University School of Medicine
1999–2003

Research

Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Nature Genetics · 2019 · 3,156 citations
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Nature Medicine · 2017 · 2,750 citations
OncoKB: A Precision Oncology Knowledge Base
JCO Precision Oncology · 2017 · 2,318 citations

David Solit
79 papers
HA
Hikmat Al-Ahmadie
79 papers
DB
Dean Bajorin
65 papers
BB
Bernard Bochner
54 papers
JR
Jonathan Rosenberg
52 papers
Eugene Pietzak
35 papers · 23 as a resident
Jonathan Rosenberg
31 papers
MT
Min Yuen Teo
30 papers
SF
Samuel Funt
28 papers · 1 as a fellow
EC
Eugene Cha
27 papers · 12 as a resident
GD
Guido Dalbagni
27 papers
VR
Victor Reuter
27 papers

Clinical trials

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
Principal investigator · Recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2022–2027
Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2018–2027
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2033